What does Talphera, Inc. do?

Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. The company's lead product candidate, Niyad, is a lyophilized formulation of nafamostat that acts as a regional anticoagulant for infusion into the extracorporeal…

What is Talphera, Inc.'s P/E and P/B ratio?

Talphera, Inc. has a P/E ratio of -4.0 and a P/B ratio of 3.78.

What is Talphera, Inc.'s debt-to-equity ratio?

Talphera, Inc. has a debt-to-equity ratio of 0.45.

How much does Talphera, Inc. owe compared with what it owns?

Talphera, Inc. owes $0.46 for every $1 it owns (balance sheet Jun 2026), which is low.

Does Talphera, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

Yes. Talphera, Inc. has 1 active red flag (PosiRed) on record: Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 13 Mar 2026). It has no yellow flags.

Where can I read the latest news about Talphera, Inc.?

Recent headlines about Talphera, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does Talphera, Inc. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of Talphera, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.

Talphera, Inc.

Q: What is Talphera, Inc.'s Positivity rank?

Talphera, Inc. is ranked #5,446 of 6,774 companies globally and #2,961 of 4,000 in United States on PositoAI, with a Positivity Score of 17,366.

NasdaqCM: TLPH · Healthcare

Positivity Index

#5,446 / 6,774

Global

#2,961 / 4,000

United States

Positivity Score

17,366

Rank→

PosiRed: 1 active red flag (highest severity 6/10) View flag history →

PosiRed · red flag

Stock exchange listing-rule deficiency notice (8-K Item 3.01)

The company reported in a Form 8-K (Item 3.01) filed on 13 Mar 2026 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.

More details →

Talphera, Inc. — Overview & Financial Snapshot

Talphera, Inc. (NasdaqCM: TLPH) is a Healthcare company, ranked #5,446 of 6,774 companies globally and #2,961 of 4,000 in United States on PositoAI, with a Positivity Score of 17,366. Its market capitalisation is ₹514.44 Cr ($54.50M), P/E ratio is -4.0 and P/B ratio is 3.78. It currently has 1 active red flag (PosiRed) and no yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →